Skip to content
  • Friday, 14 August 2026
  • 9:56 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ancient Chinese Exercise Baduanjin Proves as Effective as Brisk Walking for Lowering Blood Pressure in New Clinical Trial
Neuroscience & Brain Research

Ancient Chinese Exercise Baduanjin Proves as Effective as Brisk Walking for Lowering Blood Pressure in New Clinical Trial

Rifan Muazin May 26, 2026 0

A landmark randomized clinical trial published in JACC, the flagship journal of the American College of Cardiology, has revealed that…

Read More
Neuroscience & Brain Research

Ancient Chinese Exercise Baduanjin Proven as Effective as Brisk Walking in Reducing Blood Pressure According to Major Clinical Trial

Rifan Muazin May 19, 2026 0

A groundbreaking study published in JACC, the flagship journal of the American College of Cardiology, has revealed that Baduanjin, a…

Read More
Neuroscience & Brain Research

Ancient Chinese Exercise Practice Baduanjin Found as Effective as Brisk Walking in Reducing Blood Pressure According to New Clinical Trial

Rifan Muazin May 11, 2026 0

A groundbreaking study published in the Journal of the American College of Cardiology (JACC), the flagship publication of the American…

Read More
A ‘Super El Niño’ may be on the way. What does that mean?The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral ReefsIonis Forecasts $2 Billion Peak Sales for Tryngolza, Leveraging First-Mover Advantage in Severe HypertriglyceridemiaAnonymizing Production Data for Data Science with Mimesis: A Critical Step Towards Ethical AI and Data Compliance
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ